KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elevance Health (ELV) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Elevance Health (ELV) over the last 17 years, with Q4 2025 value amounting to 0.99%.

  • Elevance Health's EBITDA Margin fell 1700.0% to 0.99% in Q4 2025 from the same period last year, while for Dec 2025 it was 1.1%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 1.1% for FY2025, which is 600.0% down from last year.
  • Per Elevance Health's latest filing, its EBITDA Margin stood at 0.99% for Q4 2025, which was down 1700.0% from 1.23% recorded in Q3 2025.
  • Over the past 5 years, Elevance Health's EBITDA Margin peaked at 1.24% during Q4 2023, and registered a low of 0.9% during Q1 2021.
  • For the 5-year period, Elevance Health's EBITDA Margin averaged around 1.05%, with its median value being 0.99% (2022).
  • In the last 5 years, Elevance Health's EBITDA Margin soared by 9900bps in 2021 and then plummeted by -2000bps in 2022.
  • Elevance Health's EBITDA Margin (Quarter) stood at 0.96% in 2021, then decreased by -3bps to 0.93% in 2022, then surged by 33bps to 1.24% in 2023, then fell by -7bps to 1.16% in 2024, then decreased by -15bps to 0.99% in 2025.
  • Its EBITDA Margin stands at 0.99% for Q4 2025, versus 1.23% for Q3 2025 and 0.98% for Q2 2025.